Will Niraparib be included in Medicare?

Niraparib (Niraparib) is currently included in the Category B drug catalog and is limited to reimbursement to eligible patients, including for maintenance treatment of adult patients with advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who have achieved complete response or partial response to first-line platinum-containing chemotherapy; and for maintenance treatment. Maintenance treatment for adult patients with platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer after achieving complete remission or partial remission with platinum-containing chemotherapy. Patients who do not meet the conditions can only purchase it at their own expense. The price of each box of 100mg*30 capsules may be more than 5,000 yuan. The reimbursement ratio is different in different regions, and the price after reimbursement may be different.